Highly selective tritium-from-deuterium isotope separation by pulsed NH3 laser multiple-photon dissociation of chloroform

Infrared multiple-photon dissociation of CTCl₃ was investigated using a pulsed CO₂ laser-pumped NH₃ laser at 12.08 μm. No evidence of any CDCl₃ depletion or decomposition product was observed in photolyzed CTCl₃/CDCl₃ mixtures. A lower limit of the single-step T/D enrichment factor, β, was found to be ≈ 165, based on the sensitivity in measuring CDCl₃ depletion. The low-fluene CTCl₃/CDCl₃ optical selectivity in absorptions is > 9000 at the 835 cm^?1 CTCl₃ ν₄ peak.     

Time-delayed map as a model for open fluid flow

It is shown that a time-delayed map for just one (chaotic) element whose feedback is periodically interrupted can be exactly mapped to a coupled map lattice model for open fluid flow.     

Anti-oxidant and pro-oxidant reactivities of copper(II), manganese(II) and iron(III) 3,5-di-<Emphasis Type="Italic">i</Emphasis>-propylsalicylate chelates during peroxidation of alkylbenzenes

Bioactive copper(II), iron(III), and manganese(II) 3,5-di-i-propylsalicylate (3,5-DIPS) chelates were investigated in order to determine their ability to inhibit the free radical initiated chain reactions leading to the peroxidation of isopropylbenzene (i-PrPh) and ethylbenzene (EtPh). Quantitative kinetic studies of these chelates established the following order of anti-oxidant reactivities: manganese(II)-(3,5-DIPS)₂>iron(III)(3,5-DIPS)₃>copper(II)₂(3,5-DIPS)₄> > 3,5-DIPS acid. The mechanism of anti-oxidant reactivity of these three chelates is established as being due, in part, to their chain-breaking capacity resulting from the chemical reduction of the generated peroxyl radical to yield alkybenzenelhydroperoxides via reaction of the 3,5-DIPS ligand with the peroxyl radical. In the case of manganese(II)3,5-di-i-propylsalicylate, the central metalloelement also interacts with the peroxyl radical. The manganese(II)-(3,5-DIPS)₂ and copper(II)₂(3,5-DIPS)₄ chelates were also found to exhibit alkylhydroperoxide pro-oxidative reactivity leading to the formation of the alkylbenzeneperoxyl radical. In addition, the manganese(II) atom underwent oxidation to manganese(III) with the formation of the alkylbenzenehydroperoxide or superoxide with air oxygen oxidation. Amyl acetate and dipropylamine (n-Pr₂NH) were added to the reaction mixture to model the biochemical presence of ester or amine cellular components. Addition of amyl acetate to the reaction mixture increased the anti-oxidant reactivity of manganese(II)-(3,5-DIPS)₂ while decreasing its pro-oxidant reactivity. The weaker anti-oxidant reactivites of iron(III)(3,5-DIPS)₃ and copper(II)₂(3,5-DIPS)₄ were less affected by the addition of amyl acetate and the pro-oxidant reactivity of copper(II)₂(3,5-DIPS)₄ was not changed by the addition of amyl acetate, while the pro-oxidant property of iron(III)(3,5-DIPS)₃ was eliminated. In contrast to 2,6-di-t-butyl-4-methylphenol, butylated hydroxy toluene (BHT), anti-oxidant reactivities of copper(II), iron(III), and manganese(II) 3,5-DIPS chelates were dramatically enhanced by the addition of n-Pr₂NH to the reaction mixture. It is concluded that all three metalloelement chelates react with and remove alkylbenzeneperoxyl radicals and the hydroperoxyl radical. The manganese(II)-(3,5-DIPS)₂ and copper(II)₂(3,5-DIPS)₄ chelates may also be useful in removing hydroperoxides in vivo. These reactivities, in addition to their established superoxide dismutase (SOD)-mimetic and catalase-mimetic reactivities, are suggested to possibly permit anti-oxidant and pro-oxidant reactivities in aqueous and organic cellular compartments.     

Chemistry of (η5-C5H5)Ru(Ph2PCH2CH2PPh2)Cl: preparation of cationic ruthenium olefin complexes

The cationic ruthenium complexes [(η⁵-C₅H₅)Ru(Ph₂PCH₂CH₂PPh₂)L]PF₆ (L=olefin, CO, pyridine or acetonitrile) have been prepared by treatment of (η⁵-C₅H₅)Ru(Ph₂PCH₂CH₂PPh₂)Cl with L and NH₄PF₆ in methanol of 20°C.     

Rearrangement of epoxynitriles: a convenient homologation of acyclic and cyclic ketones to carboxylic acids

A convenient two-step homologation of both aliphatic and aromatic ketones to the corresponding carboxylic acid has been developed. First ketones were converted to epoxynitriles with the Darzens reaction. Second, a Lewis acid mediated rearrangement of these epoxynitriles with lithium bromide was achieved to give homologated secondary alkanoic acids (as well as aryl-alkanoic) in good yields. The mechanism and the scope of the rearrangement reaction were investigated. This strategy constitutes a two-step homologation of ketones to secondary carboxylic acids.     

Synthesis of some pyridylamino-1,4-disubstituted phthalazines

Two general procedures involving the condensation of phthalonitrile or 1,3-diiminoisoindoline with various aminopicolines, followed by ring expansion with hydrazine to the corresponding phthalazine are described. Syntheses are reported of 1, 4-di(3′-methyl-2′-pyridyl) aminophthalazine, 1,4-di(5′-methyl-2′-pyridyl)aminophthalazine, and 1,4-di(4′, 6′-dimethyl-2′-pyridyl)aminophthalazine.     

The Role of Chemistry in the Development of Boron Neutron Capture Therapy of Cancer

A therapeutic method that selectively destroys malignant cells in the presence of normal cells is a highly valued goal of oncologists and the possible salvation of cancer patients afflicted with some incurable forms of the disease. Selective cell destruction is, in principle, possible with a binary therapeutic strategy based upon the neutron capture reaction observed with the ¹⁰B nucleus and a neutron of low kinetic energy (thermal neutron). This nuclear fission reaction produces both ⁴He and ⁷Li⁺ nuclei along with about 2.4 MeV of kinetic energy and weak γ-radiation. Since the energetic and cytotoxic product ions travel only about one cell diameter in tissue one may specify the cell type to be destroyed by placing innocent ¹⁰B nuclei on or within only the doomed cells. This article describes the current status of chemical research aimed at the eventual adoption of this therapeutic method (boron neutron capture therapy or BNCT). The multidisciplinary nature of this research effort involves chemistry, biology, nuclear physics, medicine, and related specialties. Methods devised for bringing ¹⁰B nuclei to tumor cells in therapeutic amounts are correlated with the structure of a generalized cell and the various cellular compartments available for boron localization. The synthesis methods employed for the creation of boron-containing biomolecules and drugs are presented along with representative data concerning their efficacy in tumor localization. The outlook for BNCT is especially bright at this time because of rapid developments in the fields of bioorganometallic chemistry, microbiology, immunology, and nuclear science, to name but a few. Very effective boron delivery vehicles have been demonstrated, and through the interaction of chemistry and biology these species are undergoing further improvement and evaluation of their suitability for BNCT.     

Hydrogen desorption exceeding ten weight percent from the new quaternary hydride Li3BN2H8

Mobile applications of hydrogen power have long demanded new solid hydride materials with large hydrogen storage capacities. We report synthesis of a new quaternary hydride having the approximate composition Li(3)BN(2)H(8) with 11.9 wt % theoretical hydrogen capacity. It forms by reacting LiNH(2) and LiBH(4) powders in a 2:1 molar ratio either by ball milling or by heating the mixed powders above 95 degrees C. This new quaternary hydride melts at approximately 190 degrees C and releases > or =10 wt % hydrogen above approximately 250 degrees C. A small amount of ammonia (2-3 mol % of the generated gas) is released simultaneously. Preliminary calorimetric measurements suggest that hydrogen release is exothermic and, hence, not easily reversible.     

Petroleum

Ohne Zusammenfassung